Archive explorer

Browse & search snapshots

Important note

Browse and search historical snapshots. This is an archive — not current guidance or medical advice. Archived content may be incomplete, outdated, or superseded. For up-to-date recommendations, always consult the official source website.

For background on coverage and capture methods, see Methods & coverage.

Browse archived sites

Browse all sources →

Medicago Covifenz COVID-19 vaccine - Canada.ca

Health CanadaCaptures 14Latest capture Apr 11, 2026en

Medicago Covifenz COVID-19 vaccine All COVID-19 vaccines authorized in Canada are proven safe, effective and of high quality . Name: Medicago Covifenz® COVID-19 vaccine Manufacturer: Medicago Inc. Type: plant based virus-like particle Status: Cancelled by sponsor Was approved…

Notice: Period reduced for keeping clinical trial records for drugs and natural health products Health Canada is reducing the retention period for clinical trial records for drugs and natural health products from 25 years to 15 years under the Food and Drug Regulations and…

Notice of updated guidance: Applications for COVID-19 drug clinical trials under the Regulations Health Canada has updated and renamed the guidance document that was created for the interim orders No. 1 and No. 2 for COVID-19-related clinical trials. The new name is Guidance on…

Janssen Jcovden (Johnson & Johnson) COVID-19 vaccine All COVID-19 vaccines authorized in Canada are proven safe, effective and of high quality . Name: Janssen Jcovden ® COVID-19 Vaccine Manufacturer: Janssen Inc Type: Viral vector-based Status: Cancelled by sponsor Was approved…

Management of clinical trials during the COVID-19 pandemic: Notice to clinical trial sponsors From: Health Canada Updated: January 27, 2023 On this page Overview Trials Participants Changing sites Reporting an adverse event Monitoring Collecting and storing samples Distributing a…

Éthique - IRSC

Canadian Institutes of Health ResearchCaptures 54Latest capture Apr 11, 2026fr

Éthique Communiquez avec le Bureau de l'éthique : ethics-ethique@cihr-irsc.gc.ca . Erica Dobson Directrice adjointe, Excellence en recherche et Éthique erica.dobson@cihr-irsc.gc.ca Jaime Flamenbaum Conseiller principal en éthique jaime.flamenbaum@cihr-irsc.gc.ca Samuel J. Ujewe…

Notice of Compliance (NOC) Data Extract - Canada.ca

Health CanadaCaptures 12Latest capture Apr 11, 2026en

Notice of Compliance (NOC) Data Extract What is the Notice of Compliance (NOC) Data Extract? The data extract is a series of compressed ASCII text files of the database. The uncompressed size of the files is approximately 35 MB. In order to utilize the data, the file must be…

Opioid-related Harms in Canada: Integrating Emergency Medical Service, hospitalization, and death data The opioid overdose crisis continues to devastate families and communities across Canada. In response, local governments, provinces, and territories have implemented a variety…

Understanding a broader range of opioid-related hospitalizations in Canada The Public Health Agency of Canada, in collaboration with the provincial and territorial (PT) offices of Chief Coroners and Chief Medical Examiners, PT public health and health partners, and Emergency…

Opioid-related harms and mental disorders in Canada: A descriptive analysis of hospitalization data Canada is currently experiencing an opioid overdose crisis. The Public Health Agency of Canada (PHAC), in collaboration with the provincial and territorial (PT) offices of Chief…

Page 4301 of 6399Showing 43001-43010 of 63986

Early release: coverage and features are still expanding.